777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS)

Migden, M. R., Chai-Ho, W., Daniels, G. A., Wise-Draper, T. M., Kheterpal, M., Tang, J. C., Bolotin, D., Verschraegen, C., Poklepovic, A. S., Khan, S. A., Ibrahim, S. F., Zeitouni, N. C., Medina, T., Tsai, K. K., Tucci, C., Navia, S., Donthireddy, L., Bommareddy, P. K., Hou, J. W., & Davar, D. (2023). 777 Initial results from an open-label phase 1b/2 study of RP1 oncolytic immunotherapy in solid organ and hematopoietic cell transplant recipients with advanced cutaneous malignancies (ARTACUS). Regular and Young Investigator Award Abstracts. https://doi.org/10.1136/jitc-2023-sitc2023.0777
Authors:
Michael R. Migden
Wanxing Chai‐Ho
Gregory A. Daniels
Trisha M. Wise‐Draper
Meenal Kheterpal
Jennifer Tang
Diana Bolotin
Claire F. Verschraegen
Andrew Poklepovic
Shaheer Khan
Sherrif F. Ibrahim
Nathalie C. Zeitouni
Theresa Medina
Katy K. Tsai
Chris Tucci
Susan Navia
Laxminarasimha Donthireddy
Praveen K. Bommareddy
Jeannie Whit-Shan Hou
Diwakar Davar
Affiliated Authors:
Shaheer Khan
Subjects:
Chimeric Antigen Receptor T Cell Therapy (OpenAlex Topic)
Gene Therapy Techniques and Applications (OpenAlex Topic)
Immunobiology of Dendritic Cells (OpenAlex Topic)
elink
Publication Type:
Article
Unique ID:
10.1136/jitc-2023-sitc2023.0777
DOI:
10.1136/jitc-2023-sitc2023.0777
Journal:
Journal for ImmunoTherapy of Cancer
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record

Record Created: